Search Result "MVAS"
Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
Journal: Current Gene Therapy
Volume: 13 Issue: 6 Year: 2013 Page: 413-420
Author(s): Martine Goossens,Katia Pauwels,Nicolas Willemarck,Didier Breyer
MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer
Journal: Current Gene Therapy
Volume: 11 Issue: 3 Year: 2011 Page: 189-217
Author(s): Carmen E. Gomez, Jose L. Najera, Magdalena Krupa, Beatriz Perdiguero, Mariano Esteban
Mevalonate Pathway and Human Cancers
Journal: Current Molecular Pharmacology
Volume: 10 Issue: 2 Year: 2017 Page: 77-85
Author(s): Seyedeh Zahra Bathaie,Mahboobeh Ashrafi,Mahshid Azizian,Fuyuhiko Tamanoi
Vaccinia Vectors as Candidate Vaccines: The Development of Modified Vaccinia Virus Ankara for Antigen Delivery
Journal: Current Drug Targets - Infectious Disorders
Volume: 3 Issue: 3 Year: 2003 Page: 263-271
Author(s): Gerd Sutter, Caroline Staib
The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer
Journal: Current Gene Therapy
Volume: 8 Issue: 2 Year: 2008 Page: 97-120
Author(s): Carmen E. Gomez, Jose L. Najera, Magdalena Krupa, Mariano Esteban
Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease
Journal: Current Molecular Pharmacology
Volume: 10 Issue: 1 Year: 2017 Page: 13-26
Author(s): Mohammad Hashemi,Reyhane Hoshyar,Sudharsana R. Ande,Qi M. Chen,Claudia Solomon,Anne Zuse,Mohammad Naderi
Novel Synergistic Combination of Pamidronate and Temozolomide forBreast Cancer Therapeutics
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 3 Year: 2023 Page: 222-234
Author(s):
Inhibition of Smooth Muscle Cell Migration and Proliferation by Statins
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 8 Issue: 2 Year: 2008 Page: 122-140
Author(s): Lorenzo Arnaboldi, Roberta Baetta, Nicola Ferri, Agnese Granata, Stefano Bellosta, Rodolfo Paoletti, Alberto Corsini
Mucosal Vaccine Vectors: Replication-Competent Versus Replication-Deficient Poxviruses
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 2015-2023
Author(s): Lukena U. Karkhanis, Ted M. Ross
A Novel Recombinant Modified Vaccinia Ankara Virus expressingInterleukin-13 Receptor α2 Antigen for Potential CancerImmunotherapy
Journal: Current Molecular Medicine
Volume: 24 Issue: 6 Year: 2024 Page: 758-770
Author(s): Bharat H. Joshi,Syed R. Husain,Raj K. Puri